Gilead must face pay-for-delay suit
Class-action alleges pharma company blocked rival HIV drug | Health insurance trust convinces judge a reverse payment may have been made.
Jones Day hires new counsel for New York IP practice
Jones Day has announced that Yi Han Dulkeith has joined the firm’s IP practice in New York.
French healthcare company makes $1.2bn AI drug discovery deal
Partnership with San Francisco-based software biotech initially focuses on compounds for five targets | Company uses machine learning to enable structure-based drug design.
Bausch Health unit prevails in patent dispute
New Jersey court dismissed a suit regarding an oral antibiotic | Prior art invalidated plaintiff’s four patents.
Japanese pharma company wins arbitration over cancer drug
Dispute over the Enhertu began in 2019 | Antibody drug conjugate tech at issue | American Arbitration Association issued final decision.
Fed Circuit rejects Minerva patent invalidation bid
Hologic patent invented by Minerva’s founder cannot be invalidated | Patent in dispute concerns device used to treat uterine bleeding | US Court of Appeals.
Hemp group in cybersquatting clash
Illinois-based firm accuses hemp group of cybersquatting | US Court for the District of Colorado.
Rival sues Monsanto, Bayer over GM plant tech
Firms accused of using GM tech for herbicide-resistant plants | Plaintiff says its patented tech helps farmers to innovate | US District Court for the District of Delaware.
Chugai settles cancer drug patent dispute with US firm
Parties to withdraw lawsuit over lung cancer drug | ANDA generic would have displaced sales of patented version in Delaware, said plaintiff.
UK pharma firm ‘stole’ psilocybin secrets from professor
Mental health specialists in dispute over psilocybin | Terran Biosciences accuses Compass Pathways of ‘milking’ professor before ‘secretly’ filing a patent for the medicine.
